| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $328.5M | +3.2% | +1.4% |
| Cost of Revenue | $245.4M | +1.6% | -1.1% |
| Gross Profit | $83.1M | +8.1% | +9.6% |
| R&D Expense | $2.8M | — | +86.7% |
| SG&A Expense | $30.8M | -29.5% | -9.0% |
| Operating Income | $35.4M | +132.4% | +46.4% |
| Pre-tax Income | $36.9M | +106.6% | +39.0% |
| Income Tax | $12.7M | +135.6% | +10.2% |
| Net Income | $24.2M | +94.1% | +60.9% |
| EPS (Basic) | $0.30 | +100.0% | +66.7% |
| EPS (Diluted) | $0.29 | +107.1% | +70.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $131.6M | +17.3% | +20.5% |
| Accounts Receivable | $263.6M | +19.7% | -12.1% |
| Current Assets | $501.6M | -9.1% | -11.7% |
| Total Assets | $698.3M | -5.9% | -4.4% |
| Current Liabilities | $235.7M | +16.5% | -0.6% |
| Total Liabilities | $259.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $45.9M | — | -7.7% |
| Capital Expenditures | $6.3M | — | +123.3% |
| Investing Cash Flow | $96.6M | — | +202.1% |
| Financing Cash Flow | -$123.1M | — | -3644.3% |
| Free Cash Flow | $39.6M | — | -15.7% |
| -1.6% |
| Stockholders' Equity | $439.3M | -14.9% | -6.0% |